Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-20
2000-09-05
Boykin, Terressa M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
25229901, 424450, 424455, 4241951, 428 1, 428402, 544337, 544358, A01N 4360
Patent
active
061143367
ABSTRACT:
This invention relates to a cosmetic composition containing at least one NPY-antagonist component mixed with an excipient for cosmetic preparations.
REFERENCES:
patent: 5621079 (1997-04-01), Cascieri et al.
Castan et al., Endocrinology, vol. 131, No. 4, "Identification and Functional Studies of a Specific Peptide YY-Preferring Receptor in Dog Adipocytes", 1972.
Castan et al., American Physiological Society, "Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the .alpha..sub.2 -adrenergic system", E74-80, 1993.
Valet et al., J. Clin. Invest., vol. 85, "Neuropeptide Y and Peptide YY Inhibit Lipolysis in Human and Dog Fat Cells through a Pertussis Toxin-sensitive G Protein", pp. 291-295, Jan. 1990.
Chemical Abstracts, vol. 124, No. 22, (1999).
Chemical Abstracts, vol. 124, No. 6, (1999).
Blanc-Ferras Elisabeth
Bono Colombie Fran.cedilla.oise
Breda Bernard
Courregelongue Jean
Ducasse Catherine
Boykin Terressa M.
Sanofi
LandOfFree
Cosmetic composition containing a neuropeptide Y receptor antago does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosmetic composition containing a neuropeptide Y receptor antago, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosmetic composition containing a neuropeptide Y receptor antago will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212389